Role of MRD in Predicting Outcomes of Transplant in ALL

Track: BMT Tandem "Scientific" Meeting
Thursday, February 27, 2014, 12:30 PM-1:30 PM
Texas B+D (Gaylord Texan)
Robert Negrin, MD , Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA
Disclosures:
R. Negrin, Jazz Pharmaceuticals, NeoSte, Ziopharm: Consulting Fees
Concentrics: Ownership Interest
Previous Presentation | Next Presentation >>